Unbiased AI-powered news
1 stories related to this topic, newest first.
New York PostThe Food and Drug Administration has greenlit the first human clinical trial of an ibogaine derivative in the United States to test its potential as a treatment for alcohol use disorder. This follows President Trump's executive order to fast-track psychedelic research. The agency…